Johnson & Johnson (JNJ) Net Profit Margin: 21.83%
Is Johnson & Johnson’s net profit margin high or low?
Johnson & Johnson's net profit margin of 21.83% is 14% below its 5-year average of 25.39%, near the low end of its 5-year range (15.84%–41.28%).
As of Thursday, June 11, 2026. 1.44% below its 12-month average of 22.15%.
JNJ Net Profit Margin Chart
JNJ Average Net Profit Margin Chart
JNJ Current vs Average Net Profit Margin Chart
JNJ Net Profit Margin Metrics
NET PROFIT MARGIN
21.83%
NET PROFIT MARGIN AVG TTM
22.15%
NET PROFIT MARGIN AVG 3Y
27.00%
NET PROFIT MARGIN AVG 5Y
25.39%
NET PROFIT MARGIN AVG 10Y
21.47%
NET PROFIT MARGIN AVG 15Y
20.64%
NET PROFIT MARGIN AVG 20Y
20.40%
CURRENT VS TTM AVG
-1.44%
CURRENT VS 3Y AVG
-19.16%
CURRENT VS 5Y AVG
-14.03%
CURRENT VS 10Y AVG
+1.66%
CURRENT VS 15Y AVG
+5.77%
CURRENT VS 20Y AVG
+7.03%
JNJ Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $577.73B | 21.83% | 22.15% | 27.00% | 25.39% |
| Pfizer Inc. (PFE) | $149.61B | 11.83% | 12.51% | 14.97% | 18.18% |
| Merck & Co., Inc. (MRK) | $298.23B | 13.62% | 27.40% | 19.98% | 20.62% |
| AbbVie Inc. (ABBV) | $399.86B | 5.79% | 7.25% | 10.96% | 12.41% |
| Eli Lilly and Company (LLY) | $1.10T | 34.98% | 27.59% | 23.10% | 22.89% |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 15.01% | -1.95% | 6.91% | 3.59% |
Margin Comparison
Operating Margin
26.9%
Net Profit Margin
21.8%
Johnson & Johnson Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Johnson & Johnson Net Profit Margin FAQ
- What is the net profit margin for Johnson & Johnson (JNJ)?
- The net profit margin for JNJ stock is 21.83%.
- Is Johnson & Johnson's net profit margin high or low?
- Johnson & Johnson's net profit margin of 21.83% is 14% below its 5-year average of 25.39%, near the low end of its 5-year range (15.84%–41.28%).
- What is the TTM average net profit margin for Johnson & Johnson (JNJ)?
- The TTM average net profit margin for JNJ stock is 22.15%.
- What is the 3Y average net profit margin for Johnson & Johnson (JNJ)?
- The 3Y average net profit margin for JNJ stock is 27.00%.
- What is the 5Y average net profit margin for Johnson & Johnson (JNJ)?
- The 5Y average net profit margin for JNJ stock is 25.39%.
- What is the 10Y average net profit margin for Johnson & Johnson (JNJ)?
- The 10Y average net profit margin for JNJ stock is 21.47%.
- What is the 15Y average net profit margin for Johnson & Johnson (JNJ)?
- The 15Y average net profit margin for JNJ stock is 20.64%.
- What is the 20Y average net profit margin for Johnson & Johnson (JNJ)?
- The 20Y average net profit margin for JNJ stock is 20.40%.
Johnson & Johnson Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-28 | 28.46% |
| 2024-12-29 | 15.84% |
| 2023-12-31 | 41.28% |
| 2023-01-01 | 22.43% |
| 2022-01-02 | 26.52% |
| 2021-01-03 | 17.82% |
| 2019-12-31 | 18.42% |
| 2018-12-31 | 18.75% |
| 2017-12-31 | 1.70% |
| 2016-12-31 | 23.01% |
| 2015-12-31 | 21.99% |
| 2014-12-31 | 21.96% |
| 2013-12-31 | 19.40% |
| 2012-12-31 | 16.14% |
| 2011-12-31 | 14.87% |
| 2010-12-31 | 21.65% |
| 2009-12-31 | 19.82% |
| 2008-12-31 | 20.31% |
| 2007-12-31 | 17.31% |
| 2006-12-31 | 20.73% |
| 2005-12-31 | 19.92% |
| 2004-12-31 | 17.28% |
| 2003-12-31 | 17.19% |
| 2002-12-31 | 18.17% |
| 2001-12-31 | 17.54% |
| 2000-12-31 | 16.98% |
| 1999-12-31 | 15.26% |
| 1998-12-31 | 12.52% |
| 1997-12-31 | 14.60% |
| 1996-12-31 | 13.35% |
Related Metrics
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato